---
schema_version: "secwatch.filing_event.v1"
accession: "0001040130-25-000074"
form_type: "8-K"
ticker: "PETS"
cik: "0001040130"
company_name: "PETMED EXPRESS INC"
filed_at: "2025-10-14T23:59:59+00:00"
generated_at: "2026-05-17T03:50:25.105105+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# PetMed Express FY2025 net sales $227M, net loss $6.3M; Q1/Q2 filings delayed

## Summary
- Net sales of $227.0M for FY2025 below preliminary range of $231.6M-$233.6M due to restatement of promotional sales reimbursements to cost of sales.
- Net loss of $6.3M widened from preliminary estimated loss of $4.5M-$5.0M, driven by a $1.2M non-cash impairment charge for intangible assets.
- Cash balance of $54.7M and no debt as of March 31, 2025.
- Company filed Form 10-K; plans to file Q1 and Q2 2025 reports and resume normal quarterly earnings call cadence.

## SEC filing metadata
- accession: 0001040130-25-000074
- form_type: 8-K
- ticker: PETS
- cik: 0001040130
- company_name: PETMED EXPRESS INC
- filed_at: 2025-10-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1040130/000104013025000074/0001040130-25-000074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1040130/000104013025000074/pets-20251014.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001040130-25-000074
- JSON: https://secwatch.observer/filing/0001040130-25-000074.json
- Plain text: https://secwatch.observer/filing/0001040130-25-000074.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.